Atlas Trials

A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication

Clinical trial NCT04937829 · COMPLETED

Trial details

NCT number
NCT04937829
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Depressive Disorder, Major
Start date
2021-07-20
Primary completion
2023-11-16
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.